Invesco’s Takeda Pharmaceutical TAK Stock Holding History

Invesco’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$342K	Buy	+18,485	New	+$324K	﹤0.01%	3294
2025 Q3	–	Sell	-35,977	Closed	-$556K	–	3856
2025 Q2	$556K	Sell	35,977 -13,970	-28%	-$206K	﹤0.01%	3113
2025 Q1	$743K	Buy	+49,947	New	+$700K	﹤0.01%	2968
2023 Q2	–	Sell	-43,710	Closed	-$720K	–	3942
2023 Q1	$720K	Buy	+43,710	New	+$696K	﹤0.01%	3070
2022 Q4	–	Sell	-33,601	Closed	-$436K	–	4064
2022 Q3	$436K	Sell	33,601 -11,658	-26%	-$162K	﹤0.01%	3320
2022 Q2	$635K	Sell	45,259 -4,806	-10%	-$68.6K	﹤0.01%	3217
2022 Q1	$717K	Buy	+50,065	New	+$735K	﹤0.01%	3228
2019 Q4	–	Sell	-64,209	Closed	-$1.1M	–	3698
2019 Q3	$1.1M	Sell	64,209 -1,934	-3%	-$33.4K	﹤0.01%	2945
2019 Q2	$1.17M	Sell	66,143 -3,414	-5%	-$62.1K	﹤0.01%	2984
2019 Q1	$1.42M	Buy	+69,557	New	+$1.4M	﹤0.01%	2821

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco's TAK Position: Q1 2026 in Review

Invesco opened a new position in Takeda Pharmaceutical (TAK) in Q1 2026: 18,485 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #3294 among its holdings. This is a return to the name: Invesco previously reported a position in TAK as recently as Q2 2025.

Invesco first reported a position in TAK in Q1 2019 and has held it in 10 quarters since. The position peaked at $1.42M in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Invesco held 18,485 shares of Takeda Pharmaceutical worth $342K as of Q1 2026.
Takeda Pharmaceutical was a new Invesco position in Q1 2026.
Takeda Pharmaceutical made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3294 holding.
Invesco first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 10 quarters since.
Invesco's Takeda Pharmaceutical position peaked at $1.42M in Q1 2019.
358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.